Nano-X Imaging (NNOX) to Release Earnings on Monday

Nano-X Imaging (NASDAQ:NNOX) is projected to announce its Q1 2026 results before the market opens on Monday, July 20th. Analysts expect the company to announce earnings of ($0.20) per share and revenue of $4.5380 million for the quarter. Parties may visit the the company’s upcoming Q1 2026 earning report for the latest details on the call scheduled for Thursday, June 25, 2026 at 8:30 AM ET.

Nano-X Imaging (NASDAQ:NNOX) last issued its earnings results on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. The firm had revenue of $4.31 million during the quarter. On average, analysts expect Nano-X Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Nano-X Imaging Price Performance

Shares of NNOX stock opened at $1.05 on Monday. Nano-X Imaging has a fifty-two week low of $0.73 and a fifty-two week high of $5.69. The stock’s 50-day moving average is $1.64 and its two-hundred day moving average is $2.24. The firm has a market cap of $73.07 million, a P/E ratio of -0.66 and a beta of 1.24.

Institutional Investors Weigh In On Nano-X Imaging

A number of large investors have recently added to or reduced their stakes in NNOX. Virtu Financial LLC grew its holdings in Nano-X Imaging by 26.4% during the fourth quarter. Virtu Financial LLC now owns 72,535 shares of the company’s stock valued at $203,000 after purchasing an additional 15,169 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of Nano-X Imaging in the fourth quarter worth $91,000. Engineers Gate Manager LP lifted its stake in shares of Nano-X Imaging by 272.2% in the fourth quarter. Engineers Gate Manager LP now owns 52,844 shares of the company’s stock worth $148,000 after buying an additional 38,648 shares during the last quarter. Weiss Asset Management LP bought a new stake in shares of Nano-X Imaging during the 4th quarter worth $8,424,000. Finally, Russell Investments Group Ltd. boosted its holdings in shares of Nano-X Imaging by 49.0% during the 4th quarter. Russell Investments Group Ltd. now owns 20,541 shares of the company’s stock worth $58,000 after buying an additional 6,754 shares during the period. Institutional investors own 21.49% of the company’s stock.

Trending Headlines about Nano-X Imaging

Here are the key news stories impacting Nano-X Imaging this week:

• Negative Sentiment: Multiple law firms, including Rosen, Schall, Gross, Robbins, Faruqi & Faruqi, and others, issued fresh reminders about the August 11, 2026 lead-plaintiff deadline in the Nano-X securities class action, extending the overhang from the lawsuit. Article Title
• Negative Sentiment: The class action references alleged violations of federal securities laws and investor losses tied to Nano-X, which can pressure sentiment by raising fears of settlements, legal costs, and management distraction. Article Title
• Neutral Sentiment: A short-interest update reported zero shares sold short as of July 10, making the change and days-to-cover figure effectively meaningless for trading sentiment. Article Title

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Nano-X Imaging in a report on Wednesday. D. Boral Capital reissued a “buy” rating and issued a $5.00 target price on shares of Nano-X Imaging in a research report on Monday, April 20th. Alliance Global Partners lowered shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $5.00 to $3.00 in a research note on Tuesday, July 7th. Finally, Zacks Research raised shares of Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $4.00.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.